279 related articles for article (PubMed ID: 22051915)
21. [Congenital toxoplasmosis following infection occurring late in pregnancy].
Ben Abdallah R; Siala E; Maatoug R; Souissi O; Aoun K; Bouratbine A
Arch Pediatr; 2011 Jul; 18(7):758-60. PubMed ID: 21632221
[TBL] [Abstract][Full Text] [Related]
22. [Congenital toxoplasmosis: severe ocular and neurological complications].
Hoekstra F; Buzing C; Sporken JM; Erasmus CE; van der Flier M; Semmekrot BA
Ned Tijdschr Geneeskd; 2011; 155(18):A2853. PubMed ID: 21557824
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of congenital toxoplasmosis. Clinical and biological results (author's transl)].
Couvreur J; Nottin N; Desmonts G
Ann Pediatr (Paris); 1980 Dec; 27(10):647-52. PubMed ID: 7212550
[No Abstract] [Full Text] [Related]
24. Eye manifestations of congenital toxoplasmosis.
Mets MB; Holfels E; Boyer KM; Swisher CN; Roizen N; Stein L; Stein M; Hopkins J; Withers S; Mack D; Luciano R; Patel D; Remington JS; Meier P; McLeod R
Am J Ophthalmol; 1996 Sep; 122(3):309-24. PubMed ID: 8794703
[TBL] [Abstract][Full Text] [Related]
25. [Management of congenital toxoplasmosis in France: current data].
Garcia-Méric P; Franck J; Dumon H; Piarroux R
Presse Med; 2010 May; 39(5):530-8. PubMed ID: 19926248
[TBL] [Abstract][Full Text] [Related]
26. [Toxoplasmosis-chorioretinitis: clinical course and treatment of seven patients].
Lebech AM; Lebech M; Børme KK; Mathiesen LR
Ugeskr Laeger; 1996 Jul; 158(27):3935-9. PubMed ID: 8701510
[TBL] [Abstract][Full Text] [Related]
27. The ocular manifestations of congenital infection: a study of the early effect and long-term outcome of maternally transmitted rubella and toxoplasmosis.
O'Neill JF
Trans Am Ophthalmol Soc; 1998; 96():813-79. PubMed ID: 10360309
[TBL] [Abstract][Full Text] [Related]
28. [Congenital toxoplasmosis].
Conyn-van Spaendonck MA; van Knapen F; de Jong PT
Tijdschr Kindergeneeskd; 1990 Dec; 58(6):227-33. PubMed ID: 2089735
[TBL] [Abstract][Full Text] [Related]
29. [Observations of children with chorioretinitis in congenital toxoplasmosis].
Jankowska H; Szczepańska-Putz M
Pol Tyg Lek; 1992 Mar 2-9; 47(9-10):232-3. PubMed ID: 1437826
[TBL] [Abstract][Full Text] [Related]
30. Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis.
Brézin AP; Thulliez P; Couvreur J; Nobré R; Mcleod R; Mets MB
Am J Ophthalmol; 2003 Jun; 135(6):779-84. PubMed ID: 12788116
[TBL] [Abstract][Full Text] [Related]
31. Congenital toxoplasmosis: late pregnancy infections detected by neonatal screening and maternal serological testing at delivery.
Lago EG; Neto EC; Melamed J; Rucks AP; Presotto C; Coelho JC; Parise C; Vargas PR; Goldbeck AS; Fiori RM
Paediatr Perinat Epidemiol; 2007 Nov; 21(6):525-31. PubMed ID: 17937738
[TBL] [Abstract][Full Text] [Related]
32. Incidence and clinical characteristics in a Colombian cohort of ocular toxoplasmosis.
de-la-Torre A; López-Castillo CA; Gómez-Marín JE
Eye (Lond); 2009 May; 23(5):1090-3. PubMed ID: 18617902
[TBL] [Abstract][Full Text] [Related]
33. [Role of systematic ophthalmological screening for congenital toxoplasmosis: epidemiological study of an Alsatian cohort from 1990 to 2011].
Subilia-Guignier A; Villard O; Filisetti D; Escande B; Candolfi E; Speeg-Schatz C; Sauer A
J Fr Ophtalmol; 2014 May; 37(5):365-70. PubMed ID: 24698638
[TBL] [Abstract][Full Text] [Related]
34. Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis.
Delair E; Monnet D; Grabar S; Dupouy-Camet J; Yera H; Brézin AP
Am J Ophthalmol; 2008 Dec; 146(6):851-5. PubMed ID: 18723143
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of a case of severe congenital toxoplasmosis].
Pujol-Riqué M; Gómez-López L; Tudó G; Falgueras T; Costa J; Rodríguez-Miguélez JM; Coll O; Valls ME
Med Clin (Barc); 1999 Nov; 113(18):701-3. PubMed ID: 10650573
[TBL] [Abstract][Full Text] [Related]
36. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis.
Gras L; Gilbert RE; Ades AE; Dunn DT
Int J Epidemiol; 2001 Dec; 30(6):1309-13. PubMed ID: 11821335
[TBL] [Abstract][Full Text] [Related]
37. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group.
Guerina NG; Hsu HW; Meissner HC; Maguire JH; Lynfield R; Stechenberg B; Abroms I; Pasternack MS; Hoff R; Eaton RB
N Engl J Med; 1994 Jun; 330(26):1858-63. PubMed ID: 7818637
[TBL] [Abstract][Full Text] [Related]
38. [Early diagnosis and treatment of chorioretinitis in children with congenital toxoplasmosis].
Gerkowicz K
Klin Oczna; 1979; 81(2):135-7. PubMed ID: 439718
[No Abstract] [Full Text] [Related]
39. The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002.
Schmidt DR; Hogh B; Andersen O; Fuchs J; Fledelius H; Petersen E
Arch Dis Child; 2006 Aug; 91(8):661-5. PubMed ID: 16861484
[TBL] [Abstract][Full Text] [Related]
40. [Prevention of congenital toxoplasmosis in France. Risk assessment. Results and perspectives of prenatal screening and newborn follow up].
Ambroise-Thomas P; Schweitzer M; Pinon JM; Thiebaugeorges O
Bull Acad Natl Med; 2001; 185(4):665-83; discussion 684-8. PubMed ID: 11503357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
